RecruitingNCT07580144
Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients
Sponsor
Konya Meram State Hospital
Enrollment
100 participants
Start Date
May 13, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This prospective observational study aims to evaluate whether sarcopenia and frailty affect the pharmacodynamic profile of rocuronium in geriatric patients undergoing elective surgery under general anesthesia.
Eligibility
Min Age: 65 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with frailty, neuromuscular blockade, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 80 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07580144
Related Trials
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
NCT075003761 location
Comparison of Preoperative Frailty Assessment Tools
NCT068895451 location
The Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults
NCT077267581 location
The Effectiveness and Safety of Combined Research on Uremic Sarcopenia
NCT077245871 location
Exploration on the Relationship Between Distinct Sarcopenia, Traditional Chinese Medicine Body Constitution, and Circadian Rhythm Patterns of Older Adults and Impact of Acupoint-stimulated Interventions
NCT077157211 location